RCMI Coordinating Center (RCMI CC) Header Logo

Connection

David Calhoun to Sodium Chloride Symporter Inhibitors

Back to Details
This is a "connection" page, showing publications David Calhoun has written about Sodium Chloride Symporter Inhibitors.
David Calhoun
Connection Strength
0.954
Sodium Chloride Symporter Inhibitors
  1. Acelajado MC, Hughes ZH, Oparil S, Calhoun DA. Treatment of Resistant and Refractory Hypertension. Circ Res. 2019 03 29; 124(7):1061-1070.
    View in: PubMed
    Score: 0.706
  2. Czarina Acelajado M, Calhoun DA. Treatment of resistant hypertension. Minerva Cardioangiol. 2009 Dec; 57(6):787-812.
    View in: PubMed
    Score: 0.092
  3. Pimenta E, Calhoun DA. Resistant hypertension and aldosteronism. Curr Hypertens Rep. 2007 Nov; 9(5):353-9.
    View in: PubMed
    Score: 0.080
  4. Calhoun DA. Low-dose aldosterone blockade as a new treatment paradigm for controlling resistant hypertension. J Clin Hypertens (Greenwich). 2007 Jan; 9(1 Suppl 1):19-24.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support